SEC Form 4 · accession 0001171843-15-006646
IMMUNOMEDICS INC · IMMU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur S Kirsch
Director
Period of report
Dec 2, 2015
Accepted (ET)
Dec 4, 2015 · 8:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000722830
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $3.11 | Dec 2, 2015 | A | 28,821 | A | — | Dec 2, 2022 | Common Stock, par value $0.01 per share | 28,821 | 28,821 | D |
| Restricted Stock UnitsF2 | — | Dec 2, 2015 | A | 14,469 | A | — | — | Common Stock, par value $0.01 per share | 14,469 | 14,469 | D |
Explanation of responses
- F1The stock options are fully vested on the date of grant.
- F2Each restricted stock unit represents a contingent right to receive one share of Immunomedics, Inc. common stock. The restricted stock units shall vest upon the earlier of (i) the reporting person's completion of one year of service as a non-employee director from the date of grant, or (ii) the reporting person's continuation in service through the day immediately preceding the next annual stockholders meeting following the date of grant.